Skip to main content
Clinical Trials/NCT05499897
NCT05499897CompletedNot Applicable

Interscalene Brachial Plexus Block is Associated With Lower Patient-Reported Wound Symptom Scores and Altered Perioperative Biomarker Profiles Following Open Rotator Cuff Repair: An Exploratory Randomised Controlled Trial

Yuzuncu Yil University2 sites in 2 countries34 target enrollmentStarted: February 3, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
34
Locations
2
Primary Endpoint
interscalene block

Study Overview

Brief Summary

This exploratory randomized controlled trial evaluated the association of interscalene brachial plexus block (ISB) with early postoperative wound-related symptom scores and perioperative biomarker responses in patients undergoing open rotator cuff repair.

Participants were randomly allocated to receive either ultrasound-guided interscalene brachial plexus block or standardized general anaesthesia. The primary outcome was postoperative wound-related assessment using the Toronto Symptom Assessment System for Wounds (TSAS-W) on postoperative days 5 and 14. TSAS-W was used as an exploratory patient-reported wound symptom assessment tool.

Secondary outcomes included perioperative serum cytokine and growth-factor concentrations (IL-1β, IL-2, TNF-α, EGF, PDGF, and TGF-β), platelet counts, postoperative pain scores, tramadol consumption within 48 hours, time to mobilisation, and postoperative nausea and vomiting.

This study aimed to investigate whether interscalene brachial plexus block was associated with differences in perioperative biological responses and postoperative wound-related symptom scores compared with general anaesthesia.

Detailed Description

Study Design and Participants

This prospective, parallel-group randomized controlled trial included adult patients aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I-II who were scheduled for elective open rotator cuff repair.

Participants were randomly allocated in a 1:1 ratio to receive either ultrasound-guided interscalene brachial plexus block (ISB) or general anaesthesia (GA). Randomization was performed using a computer-generated block randomization sequence with a fixed block size of four. Allocation concealment was achieved using sequentially numbered opaque sealed envelopes prepared by an investigator not otherwise involved in patient care or outcome assessment.

Due to the nature of the intervention, participants and the attending anaesthesiologist were not blinded. The operating surgeon was aware of group allocation because of the visible differences in perioperative anaesthetic management. However, laboratory personnel, postoperative outcome assessors, postoperative care staff, and the statistician remained blinded to group allocation whenever feasible.

A total of 34 participants were randomized. Two participants in the general anaesthesia group were excluded after randomization (one protocol violation and one missing follow-up), leaving 32 participants (GA n=15; ISB n=17) for per-protocol analysis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Outcome assessors, laboratory personnel, postoperative care staff, and the statistician were blinded to treatment allocation whenever feasible. Due to the nature of the intervention, participants and attending anaesthesiologists were not blinded.

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients aged 18-65 years
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Scheduled for elective open repair of a full-thickness rotator cuff tear

Exclusion Criteria

  • Pregnancy or lactation
  • Known coagulopathy
  • Chronic renal insufficiency
  • Chronic hepatic insufficiency
  • Significant uncontrolled cardiopulmonary disease
  • Chronic opioid use
  • Immunosuppressive therapy
  • Diabetes mellitus or other uncontrolled metabolic disorders potentially affecting wound healing
  • Chronic inflammatory disease
  • Morbid obesity (body mass index ≥35 kg/m²)
  • Allergy to amide local anaesthetics
  • Infection at the injection site
  • Emergency surgery
  • Inability to complete postoperative assessments

Arms & Interventions

General Anesthesia Group

Active Comparator

Patients undergoing open rotator cuff repair under standardized general anaesthesia. General anaesthesia was induced with propofol, fentanyl, and rocuronium, and maintained with sevoflurane. Additional intraoperative fentanyl was administered according to haemodynamic responses. Postoperative analgesia included paracetamol and rescue tramadol.

Intervention: General Anesthesia (Procedure)

Interscalene Block Group

Experimental

Patients undergoing open rotator cuff repair with ultrasound-guided interscalene brachial plexus block using 20 mL of 0.25% bupivacaine. Surgery was performed under awake regional anaesthesia without routine sedation. Supplemental intravenous fentanyl boluses were permitted intraoperatively if clinically required according to predefined haemodynamic criteria.

Postoperative analgesia included paracetamol and rescue tramadol.

Intervention: Ultrasound-Guided Interscalene Brachial Plexus Block (Procedure)

Outcomes

Primary Outcomes

interscalene block

Time Frame: 6 monthes

number of participants with interscalene block

Early postoperative wound-related symptom scores (TSAS-W)

Time Frame: Postoperative day 5 and day 14

Early postoperative wound-related symptoms assessed using the Toronto Symptom Assessment System for Wounds (TSAS-W), a patient-reported wound symptom assessment tool originally developed for chronic wound settings. TSAS-W was used as an exploratory patient-reported symptom assessment instrument rather than as an objective measure of wound healing.

Secondary Outcomes

  • general anesthesia(6 monthes)
  • Postoperative nausea and vomiting(Within 48 hours postoperatively)
  • Time to mobilisation(Up to 48 hours after surgery)
  • Postoperative tramadol consumption(Within 48 hours postoperatively)

Investigators

Sponsor
Yuzuncu Yil University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Arzu Esen Tekeli

Associate Professor

Yuzuncu Yil University

Study Sites (2)

Loading locations...

Similar Trials

Interscalene Brachial Plexus Block and... | Clinical Trial